Sales & Marketing Views & Analysis

Views & Analysis

Bad behaviour: why understanding human behaviour can improve...

Why did I do that? A common question I often ask myself after opening the biscuit packet for the third time in an hour.

Views & Analysis

Preparing for an influx of cell and gene therapy approvals

Cell and gene therapies offer some of the most groundbreaking advancements in patient care the pharma industry has ever seen.

Podcasts

Novartis, company culture and COVID-19: the pharmaphorum pod...

Novartis’ Steven Baert joined the pharmaphorum podcast for episode 22 to discuss how COVID-19 will change the face of company culture, now and in the future.

Views & Analysis

Next wave: how pharma analytics can be improved with new tec...

Pharmaceutical companies have always had access to a steady stream of data to look at what has happened in the past and to try to predict future prescribing trends.

Views & Analysis

Country focus: Iraq’s pharma industry sees upward trajectory

After decades of turmoil, Iraq’s healthcare sector is growing fast – but the country still holds some unique challenges for companies looking to enter its market.

Views & Analysis

How modular content provides ‘light-speed’ review and boosts...

Twenty-first century communications are fast, personalised and multi-channel – all of which can seem diametrically opposed to the heavily-regulated world of the pharmaceutical industry.

Bad behaviour: why understanding human behaviour can improve...

Preparing for an influx of cell and gene therapy approvals

Novartis, company culture and COVID-19: the pharmaphorum pod...

Next wave: how pharma analytics can be improved with new tec...

Country focus: Iraq’s pharma industry sees upward trajectory

How modular content provides ‘light-speed’ review and boosts...

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Views & Analysis

Editor's Picks